BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Di Nicolantonio F, Vitiello PP, Marsoni S, Siena S, Tabernero J, Trusolino L, Bernards R, Bardelli A. Precision oncology in metastatic colorectal cancer - from biology to medicine. Nat Rev Clin Oncol 2021;18:506-25. [PMID: 33864051 DOI: 10.1038/s41571-021-00495-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Reyes JM. Medicina de precisión en cáncer colorrectal y gastroesofágico avanzado. Revista Médica Clínica Las Condes 2022;33:125-39. [DOI: 10.1016/j.rmclc.2022.03.003] [Reference Citation Analysis]
2 Chen J, Wu Y, Luo X, Jin D, Zhou W, Ju Z, Wang D, Meng Q, Wang H, Fu X, Xu J, Song Z. Circular RNA circRHOBTB3 represses metastasis by regulating the HuR-mediated mRNA stability of PTBP1 in colorectal cancer. Theranostics 2021;11:7507-26. [PMID: 34158864 DOI: 10.7150/thno.59546] [Reference Citation Analysis]
3 Ciardiello D, Famiglietti V, Napolitano S, Esposito L, Pietrantonio F, Avallone A, Maiello E, Cremolini C, Troiani T, Martinelli E, Ciardiello F, Martini G. Final results of the CAVE trial in RAS wild type metastatic colorectal cancer patients treated with cetuximab plus avelumab as rechallenge therapy: Neutrophil to lymphocyte ratio predicts survival. Clinical Colorectal Cancer 2022. [DOI: 10.1016/j.clcc.2022.01.005] [Reference Citation Analysis]
4 Tang YP, Yin YX, Xie MZ, Liang XQ, Li JL, Li KZ, Hu BL. Systematic Analysis of the Clinical Significance of Hyaluronan-Mediated Motility Receptor in Colorectal Cancer. Front Mol Biosci 2021;8:733271. [PMID: 34765644 DOI: 10.3389/fmolb.2021.733271] [Reference Citation Analysis]
5 Zhao L, Yu Q, Gao C, Xiang J, Zheng B, Feng Y, Li R, Zhang W, Hong X, Zhan Y, Xiao L, Hu T. Studies of the Efficacy of Low-Dose Apatinib Monotherapy as Third-Line Treatment in Patients with Metastatic Colorectal Cancer and Apatinib’s Novel Anticancer Effect by Inhibiting Tumor-Derived Exosome Secretion. Cancers 2022;14:2492. [DOI: 10.3390/cancers14102492] [Reference Citation Analysis]
6 Mauri G, Vitiello PP, Sogari A, Crisafulli G, Sartore-Bianchi A, Marsoni S, Siena S, Bardelli A. Liquid biopsies to monitor and direct cancer treatment in colorectal cancer. Br J Cancer 2022. [PMID: 35264786 DOI: 10.1038/s41416-022-01769-8] [Reference Citation Analysis]
7 Menon S, Parakh S, Scott AM, Gan HK. Antibody-drug conjugates: beyond current approvals and potential future strategies. Exploration of Targeted Anti-tumor Therapy. [DOI: 10.37349/etat.2022.00082] [Reference Citation Analysis]
8 Ciardiello F, Ciardiello D, Martini G, Napolitano S, Tabernero J, Cervantes A. Clinical management of metastatic colorectal cancer in the era of precision medicine. CA Cancer J Clin 2022. [PMID: 35472088 DOI: 10.3322/caac.21728] [Reference Citation Analysis]
9 Almuzzaini B, Alghamdi J, Alomani A, AlGhamdi S, Alsharm AA, Alshieban S, Sayed A, Alhejaily AG, Aljaser FS, Abudawood M, Almajed F, Samman A, Balwi MAA, Aziz MA. Identification of Novel Mutations in Colorectal Cancer Patients Using AmpliSeq Comprehensive Cancer Panel. J Pers Med 2021;11:535. [PMID: 34207827 DOI: 10.3390/jpm11060535] [Reference Citation Analysis]
10 Tsiakanikas P, Adamopoulos PG, Tsirba D, Artemaki PI, Papadopoulos IN, Kontos CK, Scorilas A. High Expression of a tRNAPro Derivative Associates with Poor Survival and Independently Predicts Colorectal Cancer Recurrence. Biomedicines 2022;10:1120. [DOI: 10.3390/biomedicines10051120] [Reference Citation Analysis]
11 Burlaka AA, Makhmudov DE, Lisnyi II, Paliichuk AV, Zvirych VV, Lukashenko AV. Parenchyma-sparing strategy and oncological prognosis in patients with colorectal cancer liver metastases. World J Surg Onc 2022;20. [DOI: 10.1186/s12957-022-02579-1] [Reference Citation Analysis]
12 Liu S, Chen X, Lin T. Emerging strategies for the improvement of chemotherapy in bladder cancer: Current knowledge and future perspectives. Journal of Advanced Research 2021. [DOI: 10.1016/j.jare.2021.11.010] [Reference Citation Analysis]
13 Liu F, Dai Z, Cheng Q, Xu L, Huang L, Liu Z, Li X, Wang N, Wang G, Wang L, Wang Z. LncRNA-targeting bio-scaffold mediates triple immune effects for postoperative colorectal cancer immunotherapy. Biomaterials 2022;284:121485. [DOI: 10.1016/j.biomaterials.2022.121485] [Reference Citation Analysis]
14 Calegari MA, Stefano BD, Basso M, Carbone C, Camarda F, Ribelli M, Anghelone A, Vivolo R, Bensi M, Martini M, Pozzo C, Vellone M, Ardito F, Salvatore L, Giuliante F, Tortora G. Conversion Therapy With Encorafenib and Cetuximab for Chemo-Refractory BRAF V600E-Mutated Liver-Limited Colorectal Cancer Metastasis: The First Case Report. Clin Colorectal Cancer 2021:S1533-0028(21)00088-8. [PMID: 34629317 DOI: 10.1016/j.clcc.2021.09.002] [Reference Citation Analysis]
15 Caputo V, De Falco V, Ventriglia A, Famiglietti V, Martinelli E, Morgillo F, Martini G, Corte CMD, Ciardiello D, Poliero L, De Vita F, Orditura M, Fasano M, Franco R, Caraglia M, Avitabile A, Scalamogna R, Marchi B, Ciardiello F, Troiani T, Napolitano S. Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience. Ther Adv Med Oncol 2022;14:175883592210968. [DOI: 10.1177/17588359221096878] [Reference Citation Analysis]
16 Fröhling S. Interdisciplinary team science to understand and intercept rare cancers. Molecular & Cellular Oncology 2021;8:1997331. [DOI: 10.1080/23723556.2021.1997331] [Reference Citation Analysis]
17 Chowdhury S, Hofree M, Lin K, Maru D, Kopetz S, Shen JP. Implications of Intratumor Heterogeneity on Consensus Molecular Subtype (CMS) in Colorectal Cancer. Cancers (Basel) 2021;13:4923. [PMID: 34638407 DOI: 10.3390/cancers13194923] [Reference Citation Analysis]
18 Rodriquenz MG, Ciardiello D, Latiano TP, Maiorano BA, Martinelli E, Silvestris N, Ciardiello F, Maiello E. Exploring biological heterogeneity and implications on novel treatment paradigm in BRAF-mutant metastatic colorectal cancer. Crit Rev Oncol Hematol 2022;173:103657. [PMID: 35337969 DOI: 10.1016/j.critrevonc.2022.103657] [Reference Citation Analysis]